1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In-depth patient-specific analysis of tumor heterogeneity in melanoma brain metastasis : Insights from spatial transcriptomics and multi-region bulk sequencing
- Contribution to journal › Article
- 2023
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
- Contribution to journal › Article
- 2021
-
Mark
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
Rodrigues, Joana M. LU ; Nikkarinen, Anna ; Hollander, Peter ; Weibull, Caroline E. ; Räty, Riikka ; Kolstad, Arne ; Amini, Rose Marie ; Porwit, Anna LU ; Jerkeman, Mats LU and Ek, Sara LU
, et al.
(2021)
In British Journal of Haematology
193(3).
p.520-531
- Contribution to journal › Article
-
Mark
The tumor immune microenvironment and clinical outcome in patients with esophageal and gastric adenocarcinoma
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma : Relationship with mismatch repair status and survival
Svensson, Maria C. LU ; Borg, David LU ; Zhang, Cheng ; Hedner, Charlotta LU ; Nodin, Björn LU ; Uhlén, Mathias ; Mardinoglu, Adil ; Leandersson, Karin LU
and Jirström, Karin
LU
(2019)
In Frontiers in Oncology
9(MAR).
- Contribution to journal › Article
-
Mark
The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
- Contribution to journal › Article
-
Mark
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
Berntsson, Jonna LU ; Eberhard, Jakob LU ; Nodin, Björn LU ; Leandersson, Karin LU
; Larsson, Anna H.
LU
and Jirström, Karin
LU
(2018)
In OncoImmunology
7(8).
- Contribution to journal › Article
- 2017
-
Mark
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer
van Hooren, Luuk ; Sandin, Linda C ; Moskalev, Igor ; Ellmark, Peter LU
; Dimberg, Anna
; Black, Peter
; Tötterman, Thomas H
and Mangsbo, Sara M
(2017)
In European Journal of Immunology
47(2).
p.385-393
- Contribution to journal › Article
- 2015
-
Mark
Kick-starting the cancer-immunity cycle by targeting CD40
Ellmark, Peter LU
; Mangsbo, S. M.
; Furebring, C.
; Totterman, T. H.
and Norlen, P.
(2015)
In OncoImmunology
4(7).
p.1011484-1011484
- Contribution to journal › Debate/Note/Editorial